欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/6127/001
药品名称Ambofoz 200/6 microgram/dosis, aërosol, oplossing
活性成分
    • Beclometasone dipropionate 200.0 µg
    • Formoterol fumarate 6.0 µg
剂型Pressurised inhalation, solution
上市许可持有人Medical Valley Invest AB Bradgardsvagen 28 2 Tr 236 32 Hollviken Skane Lan Sweden
参考成员国 - 产品名称Netherlands (NL)
Beclometasone/Formoterol Xiromed 200/6 microgram/dosis, aërosol, oplossing
互认成员国 - 产品名称
    • Norway (NO)
    • Denmark (DK)
    • Sweden (SE)
许可日期2025/09/29
最近更新日期2025/09/29
药物ATC编码
    • R03AK08 formoterol and beclometasone
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Other
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2026 Drugfuture->European Union HMA Authorisation of Medicines DataBase